Syncona Shs GBP ( (GB:SYNC) ) has shared an update.
Syncona Limited announced that as of 28 February 2025, the total number of ordinary shares in issue is 672,214,632, with 52,718,637 shares held in treasury, resulting in 619,495,995 voting rights. This figure is crucial for shareholders to determine their notification obligations under the FCA’s Disclosure Guidance and Transparency Rules. This announcement provides transparency and clarity on the company’s share structure, which is important for stakeholders to understand their voting rights and obligations, potentially impacting shareholder decisions and company governance.
More about Syncona Shs GBP
Syncona Limited is a life sciences investment company focused on creating, building, and scaling companies to deliver transformational treatments in areas of high unmet need. The company aims to maintain a diversified portfolio of 20-25 globally leading life science businesses across various development stages, modalities, and therapeutic areas. Syncona collaborates with world-class academic founders and experienced management teams to develop treatments that improve patient outcomes, particularly for those with limited or poor treatment options. The company’s strategy is supported by a strong balance sheet, allowing for long-term investments to build sustainable life science companies and deliver strong risk-adjusted returns to shareholders.
YTD Price Performance: -9.56%
Average Trading Volume: 737,399
Technical Sentiment Consensus Rating: Buy
For a thorough assessment of SYNC stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com